Amphastar Pharmaceuticals, Inc. (AMPH) NASDAQ
18.45
+0.03(+0.16%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
18.45
+0.03(+0.16%)
Currency In USD
| Market Cap | 1.25B |
| Enterprise Value | 1.74B |
| P/E Ratio | 10.55 |
| PEG Ratio | -0.25 |
| Price/Sales Ratio | 1.13 |
| Price/Book Ratio | 1.08 |
| Enterprise/Revenue | 1.84 |
| Enterprise/EBITDA | 8.52 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.11 |
| Operating Margin | 0.16 |
| Return On Assets | 0.05 |
| Return On Equity | 0.1 |
| Revenue | 719.89M |
| Revenue/Share | 15.9 |
| Gross Profit | 356.06M |
| EBITDA | 149.1M |
| Net Income | 98.09M |
| Diluted EPS | 2.03 |
| Total Cash | 294.39M |
| Total Cash/Share | 6.5 |
| Total Debt | 686.38M |
| Total Debt/Equity | 0.89 |
| Current Ratio | 3.85 |
| Book Value Per Share | 17.06 |
| 52-Week Change | -27.3 |
| 52-Week High | 31.26 |
| 52-Week Low | 16.65 |
| Moving Average 50 Days | 20.19 |
| Moving Average 200 Days | 24.72 |
| Average Volume | 610,046 |
| Shares Outstanding | 44.09M |
| % Held by Institutions | 68.63 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |